Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON Share Price    (BICN)

Here is the latest stock price and chart of Biocon Ltd. For more details, see the Biocon Ltd company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

Read Now: When the Dust Settles, This Stock Would Have Potentially Created Millionaires
REFRESH
Live BSE Quotes Mar 31, 2020 (Close)
Price (Rs)270.60 Open (Rs) 282.00 High (Rs) 282.00 Low (Rs) 268.20
% Change-1.74 Volume 104,656 Value (Rs) 28,478,833 52-Week H/L 323.30 / 211.30
Live NSE Quotes Mar 31, 2020 (Close)
Price (Rs)270.55 Open (Rs) 278.00 High (Rs) 281.85 Low (Rs) 268.10
% Change-1.83 Volume 3,740,173 Value (Rs) 1,018,042,222 52-Week H/L 323.50 / 211.05
Valuation
EPS (Rs)* 11.49 P/E Ratio (x) 23.56 Market Cap (Rs m) 162,360.00 P/BV (x) 2.66
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

BIOCON Share Price Today:

BIOCON last traded price was down 1.7% to Rs 270.6 on the BSE. On the NSE, BIOCON last traded price was down 1.8% to Rs 270.6. The total volume of shares traded was 3.8 m.

Overall, the broader S&P BSE HEALTHCARE Index was up by 3.4%. And the benchmark S&P BSE SENSEX was at 29,468.5 (up 3.6%).

Over the last 30 days, the BIOCON share price is down 4.1%. And over the last one year, BIOCON share price is down 12.5%.




What else is happening in the markets today? Dig in...



Today's Market

Sensex Zooms 1,028 Points; Oil & Gas, FMCG and Metal Stocks Rally(Closing)

Indian share markets continued to trade in the green during closing hours and ended their day on a strong note, tracking global cues.

Related Views On News

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

If I Were to Recommend One Stock Amid Coronavirus Outbreak, This Would be It. (Profit Hunter)

Mar 19, 2020

Coronavirus outbreak has made no impact on the long term prospects of my favourite smallcap. What it has indeed done is brought the company below my buy price, making it even more attractive investment at current price.

Why India Will Be the Biggest Winner in a Post-Coronavirus World (The 5 Minute Wrapup)

Mar 19, 2020

The way businesses operate will change in a major way post the coronavirus impact. Here's why India stands to benefit from this change...

A Big Trading Opportunity is Coming Your Way Soon (Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock (Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

TRACK BIOCON

BIOCON - ADCOCK INGRAM COMPARISON

COMPARE BIOCON WITH

MARKET STATS